Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
icosapent ethyl
/
Generic mfg.
Welcome,
Profile
Billing
Logout
26 Diseases
7 Trials
7 Trials
4331 News
«
1
2
...
39
40
41
42
43
44
45
46
47
48
49
50
51
»
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
Hi Dr Bhatt, is there a brand name pill that contains icosapent ethyl these patients could use? Haha. Just kidding. Go Vascepa!!! Thanks for all you do. $Amrn
(Twitter) - Sep 20, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical, Pricing:
CRITICALLY important that patients have access to icosapent ethyl as soon as possible to save lives and prevent cardiac events which can be stopped. Delays cost lives. @US_FDA $AMRN #icosapentethyl #vascepa
(Twitter) - Sep 20, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
NLA endorses icosapent ethyl for use in high-risk patients https://t.co/IUqs5tv5lx
(Twitter) - Sep 19, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
Please fund more Alzheimer's trials for Icosapent ethyl. One small trial is not enough.
(Twitter) - Sep 19, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
~ hope someone has at least mentioned Vascepa as a possible preventative there. ~ i know a V patient that claimed it healed their glaucoma (n = 1)
(Twitter) - Sep 19, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
~ why wouldn't you prescribe Vascepa to patients with a past stroke that may be at risk for dementia? better alternatives?
(Twitter) - Sep 19, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
This analysis was recently published (slide showing rate ratios of total events in PBO group ⬆️ w/⬆️ TG tertiles); explains the PBO grp in REDUCE-IT (lipids/inflammation/more events) while icosapent ethyl ⬇️ TGs hsCRP CV events etc in tx arm #ESC365 @DLBHATTMD @SABOURETCardio https://t.co/HMK0UpJXrU
(Twitter) - Sep 19, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
How do you get Vascepa covered for patients with elevated TG?
(Twitter) - Sep 18, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Grand rounds:
Outstanding lecture this morning at @UMJMHCardiology Cardiology Grand Round with Dr. Carl Orringer. He presented updates on #REDUCEIT Trial, #cholesterol #lipids, #cvprev and answered ques on #Omega3 #vascepa. @nationallipid @DLBHATTMD @umiamimedicine @UMiamiHealth
(Twitter) - Sep 18, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
You better start prescribing Vascepa to save people from themselves! From an RD!
(Twitter) - Sep 18, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
Does icosapent ethyl prevent/reduce microalbuminuria @DLBHATTMD ? These patients may not be under a nephrologists care but most would be under PCP’s care as we know. But if there is a window of opportunity to reverse the course it would be important to know/study. @DrAlfaddagh
(Twitter) - Sep 17, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
@ProfDFrancis I would be interested in your view on the drug Vascepa. Thank you.
(Twitter) - Sep 17, 2019
|
|||||||||
Vascepa
(icosapent ethyl) /
Amarin
That is a ringing endorsement for $AMRN and another positive take on Vascepa. Keep em' coming
(Twitter) - Sep 17, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Icosapent Ethyl was given a Class I (highest position) by @nationallipid the medical society that is expert in lipidology. As a leader in preventive cardiology, they are wasting no time to prevent #heartattacks #strokes 👍#TimeIsBrain #TimeIsHeartMuscle @mmillermd1 @DLBHATTMD
(Twitter) - Sep 15, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical, FDA event:
Dr. Dapo - what percentage of your statin treated patients do you see Icosapent Ethyl fitting, assuming FDA approves expanded label for same group as NLA & ADA guidelines?
(Twitter) - Sep 15, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
National Lipid Association @nationallipid has released its position statement on the use of #fishoil derivative Icosapent Ethyl. #cardiotwitter #medtwitter #cardioed #meded #accfit #ahafit @DLBHATTMD @carlorringer @tljA
(Twitter) - Sep 15, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
Vascepa offered ?
(Twitter) - Sep 14, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
I like how the ESC guidelines emphasize ApoB, atherogenic lipoproteins, specify use of icosapent ethyl. Much education needed on ApoB, atherogenic lipoproteins, residual risk beyond LDL-C lowering. Yearly ACC/AHA updates would be nice similar to @AmDiabetesAssn & @TheAACE
(Twitter) - Sep 14, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
A ground-breaking addition to NLA and ADA guidelines. Vascepa is also recommended by AHA and ESC for dyslipidemic patients with TG between 135 - 499 despite statin treatment. @US_FDA should follow with an expanded label approval.
(Twitter) - Sep 14, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
“CVS Caremark has started letting clients use ICER's work in coverage decisions.” https://t.co/nFpqtL3zvu #followfriday #medtwitter #cardiology #medstudenttwitter #cardiotwitter #SoMeDocs #Tweetatricians #cvprev #fishoil #omega3 #medtwitter @DLBHATTMD $amrn #vascepa #NLAFallCLU
(Twitter) - Sep 14, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
More attention needed to offer women non-statins like Vascepa. #followfriday #medtwitter #cardiology #medstudenttwitter #cardiotwitter #SoMeDocs #Tweetatricians #cvprev #fishoil #omega3 #medtwitter $amrn #vascepa @independent @jimcramer @DLBHATTMD #NLAFallCLU
(Twitter) - Sep 14, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
Not all fish oil is the same ! https://t.co/qmjXKvpw5r #followfriday #medtwitter #cardiology #medstudenttwitter #cardiotwitter #SoMeDocs #Tweetatricians #cvprev #fishoil #omega3 #medtwitter $amrn #vascepa @independent @jimcramer @DLBHATTMD #NLAFallCLU #endotwitter #cardiology
(Twitter) - Sep 14, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
https://t.co/DCewsm1fQo Another major adoption to Vascepa in last 2 weeks ! #followfriday #medtwitter #cardiology #medstudenttwitter #cardiotwitter #SoMeDocs #Tweetatricians #cvprev #fishoil #omega3 #medtwitter $amrn #vascepa @independent @jimcramer #NLAFallCLU @DLBHATTMD
(Twitter) - Sep 14, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
Plus, interpretations of these other non-TG potential mechanisms (i.e. lowering apoB, LDL-C, hsCRP) that may be responsible for some MACE reduction by Vascepa in REDUCE-IT are confounded by mineral oil (MO) placebo group. Not enough current evidence to support or refute MO issue.
(Twitter) - Sep 14, 2019
||
||||||||
Acasti's CaPre, Matinas' MAT9001, Astrazeneca's Epanova, Lovaza, Omacor, Omtryg, Vascepa. All purified omega-3 products. Differences in type/mix of omega-3 ( EPA/DHA/DPA) & chemical form. Jury still out on EPA-specific effects. At same dose, all similar? https://t.co/iKCeZN796c
(Twitter) - Sep 14, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
But none of those other potential omega-3 mechanisms have been proven in clinical trials. EPA ethyl ester (Vascepa, icosapent ethyl) developed as a TG lowering drug and tested in CVOT in elevated TG population. First impressions (TG drug) are hard to break.
(Twitter) - Sep 14, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
EPA has several mechanisms which can explain the CV benefits observed as you know. I am not sure that guidelines based on TG levels correspond to the optimal strategy for icosapent ethyl.
(Twitter) - Sep 14, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
I hope to see you and shaken your hand at the November 14 ADCOM for Eicosapentaenoic Acid, Vascepa.
(Twitter) - Sep 14, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
FDA event:
@FDACommissioner, @US_FDA .....just so you know. Vascepa is now SOC by ADA, ESC and now NLA. Endorsed by AHA and ACC. Reduce-It is published in the NEJM. Priority Review status Healthcare Canada. And the FDA decided to hold an Adcom? Something doesn't jive...
(Twitter) - Sep 13, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
The NLA today opened the 2019 Fall CLU with release of a position on use of icosapent ethyl in high- and very-high-risk patients. @nationallipid #NLAFallCLU @mmillermd1 @CBallantyneMD @rblument1 @Drlipid @EugeniaGianos @rauldsf_santos @alanbrownmd @DaveDixonPharmD @drpablocorral
(Twitter) - Sep 13, 2019
|||||
|||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
Important new statement today from @nationallipid on the use of #Vascepa in high or very-high risk CV patients! #CVInnovation @ACCinTouch @TheAACE @advcardiohealth @Amarincorp @WomenHeartOrg @MendedHearts @NatForumHDSP @lipiddoc @HeartNurses @KimPcna @ABCardio1 @ADA_DiabetesPro
(Twitter) - Sep 13, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Icosapent ethyl: Where will it fit into guideline-based medical therapy for high risk atherosclerotic cardiovascular disease? @DLBHATTMD @ProfKausikRay @pabeda1 @pablocorral23 @AngoulvantD @Khanoyan_cardio https://t.co/9mqP4uq2AW
(Twitter) - Sep 13, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
Breaking News: NLA Position on the Use of Icosapent Ethyl in High and Very High Risk Patients @nationallipid @DrMarthaGulati @ErinMichos @DLBHATTMD @VietHeartPA @TerraPharma1 Visit the NLA website https://t.co/JxHGFwjNzS and follow #NLAFallCLU https://t.co/3AyaP79SMp
(Twitter) - Sep 13, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
The protocol for reduce it include patients with triglycerides >135, those with limits between 135 and 170 probably when having #vascepa analytical test are below 135, did these patients benefit? So why put a limit on the label? @Amarincorp @DLBHATTMD
(Twitter) - Sep 13, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
NLA Position Paper of use of Icosapent Ethyl in High and Very-High-Risk patients @nationallipid #NLAFallCLU @NYUCVDPrevent
(Twitter) - Sep 13, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
I'm attending NLA Position Statement on the Use of Icosapent Ethyl in High- or Very-high Risk Patients https://t.co/KUqZ18uHKO
(Twitter) - Sep 13, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
PDUFA date, sNDA:
$AMRN confirms extension of Vascepa sNDA PDUFA to 12/28/19 https://t.co/QjhL4NsYfu
(Twitter) - Sep 12, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
PDUFA date:
$AMRN 8K - Vascepa EMDAC- 11/14/19, PDUFA - 12/28/19. Always fun to have a PDUFA the Christmas holiday week! @AndyBiotech @adamfeuerstein
(Twitter) - Sep 12, 2019
|
|||||||||
Vascepa
(icosapent ethyl) /
Amarin
Vascepa Advisory Committee Is Latest Outpost In Product's Remarkable Regulatory Journey https://t.co/D0OnEN4nau #PinkSheet
(Twitter) - Sep 12, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
@practiceupdate Practice Update, you have your Take Home Message backwards. It should read " At doses of 4 g per day, EPA alone, but not EPA/DHA decreased LDL cholesterol as well as triglyceride levels" @DLBHATTMD #cardiotwitter #vascepa https://t.co/KMtagml9t6
(Twitter) - Sep 10, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
FDA event:
Icosapent Ethyl Receives Priority Review from FDA: what about France 🇫🇷 ? @DLBHATTMD @ErinMichos @pabeda1 @drpablocorral @AngoulvantD @HeartOTXHeartMD @MeralKayikciog1 @ProfKausikRay https://t.co/AZxpJMmbSh
(Twitter) - Sep 9, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
@DLBHATTMD where there is a will there is a way!- the first Egyptian patient on Icosapent ethyl in Cairo , 31 Y old secondary prevention , premature CAD , profile similar to REDUCE IT patients
(Twitter) - Sep 8, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
PDUFA date, Adverse events:
I agree RT @ra_fun: @SecAzar @HHSGov @CDCDirector @FDACommissioner Please do not delay the approval of a cardiovascular drug VASCEPA (no side effects). It has been proven to reduce cardiovascular death by 20% and stroke by 30%. PDUFA date is September 28. @DLBHATTMD @NEJM
(Twitter) - Sep 6, 2019
||||
||||||
Vascepa
(icosapent ethyl) /
Amarin
PDUFA date, Adverse events:
Please do not delay the approval of a cardiovascular drug VASCEPA (no side effects). It has been proven to reduce cardiovascular death by 20% and stroke by 30%. PDUFA date is September 28. @DLBHATTMD @NEJM
(Twitter) - Sep 6, 2019
||
||||||||
Vascepa
(icosapent ethyl) /
Amarin
What tricks do people have to get Vascepa covered?
(Twitter) - Sep 5, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
Reduce-It didn’t show a correlation between TG reduction and a CV risk reduction. Mason’s studies theorize it’s not a TG effect. Limiting to patients >135 is because of the inclusion criteria of the study. That doesn’t mean Vascepa couldn’t help patients <135, but we don’t know.
(Twitter) - Sep 2, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
Clinical:
One big Q in HFrEF space is may there be benefit/safety if carefully used for Class IV, though we know mainly II & III was studied. Would love to know & have more research/answers evolve. Also need research w/icosapent ethyl in HF but for now, we’ll take DAPA-HF & run w/it 😉
(Twitter) - Sep 2, 2019
||||||
||||
Vascepa
(icosapent ethyl) /
Amarin
Combination therapy:
Highlights from #MedscapeLIVE "Reducing Residual Risk for #CVD: Omega-3 Fatty Acids in Cardiology Practice" at #ESCCongress: 7) Recently published @escardio guidelines recommend the use of icosapent ethyl in combination with statin therapy. -w/ Dr. @DLBHATTMD #cardiotwitter
(Twitter) - Sep 2, 2019
|||
|||||||
Vascepa
(icosapent ethyl) /
Amarin
sNDA:
$MTNB - Huge!! Buy $AMRN Buy $MTNB Panel Vote on Vascepa sNDA will be 12-O in favor @DLBHATTMD Unanimous on Nov. 14es w.
(Twitter) - Sep 1, 2019
|
|||||||||
Vascepa
(icosapent ethyl) /
Amarin
Does this confirms the benefits of Vascepa vs other fish oil?
(Twitter) - Sep 1, 2019